Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required. Learn more
Read instantly on your browser with Kindle for Web.
Using your mobile phone camera - scan the code below and download the Kindle app.
Unhinged: The Trouble with Psychiatry - A Doctor's Revelations about a Profession in Crisis Hardcover – May 18, 2010
- Kindle
$0.00 Read with Kindle Unlimited to also enjoy access to over 3 million more titles $16.99 to buy - Hardcover
$49.9514 Used from $35.00 2 Collectible from $198.81
Psychiatrists have settled for treating symptoms rather than causes, embracing the apparent medical rigor of DSM diagnoses and prescription in place of learning the more challenging craft of therapeutic counseling, gaining only limited understanding of their patients’ lives. Talk therapy takes time, whereas the fifteen-minute "med check" allows for more patients and more insurance company reimbursement. Yet DSM diagnoses, he shows, are premised on a good deal less science than we would think.
Writing from an insider’s perspective, with refreshing forthrightness about his own daily struggles as a practitioner, Dr. Carlat shares a wealth of stories from his own practice and those of others that demonstrate the glaring shortcomings of the standard fifteen-minute patient visit. He also reveals the dangers of rampant diagnoses of bipolar disorder, ADHD, and other "popular" psychiatric disorders, and exposes the risks of the cocktails of medications so many patients are put on. Especially disturbing are the terrible consequences of overprescription of drugs to children of ever younger ages. Taking us on a tour of the world of pharmaceutical marketing, he also reveals the inner workings of collusion between psychiatrists and drug companies.
Concluding with a road map for exactly how the profession should be reformed, Unhinged is vital reading for all those in treatment or considering it, as well as a stirring call to action for the large community of psychiatrists themselves. As physicians and drug companies continue to work together in disquieting and harmful ways, and as diagnoses—and misdiagnoses—of mental disorders skyrocket, it’s essential that Dr. Carlat’s bold call for reform is heeded.
- Print length272 pages
- LanguageEnglish
- PublisherFree Press
- Publication dateMay 18, 2010
- Dimensions6 x 1 x 9 inches
- ISBN-109781416590798
- ISBN-13978-1416590798
The Amazon Book Review
Book recommendations, author interviews, editors' picks, and more. Read it now
What other items do customers buy after viewing this item?
Editorial Reviews
Review
“A psychiatrist looks deeply into the mirror and takes stock of his profession and what it has become. Whether you are a patient, student, trainee, clinician, or “KOL” (key opinion leader”), this frank and insightful book will definitely make you think.” (Erick Turner, M.D., Department of Psychiatry and Center for Ethics in Health Care, Oregon Health & Science University)
"Unhinged provides crucial insights for anyone who cares about the future of Psychiatry. Must reading for psychiatrists and patients alike." (Keith Ablow, MD, author of Living the Truth)
"Terrific book, terrific insights! Daniel Carlat is the kind of psychiatrist we wish we all had." (Manny Alvarez, MD, Senior Managing Health Editor at Fox News Channel)
About the Author
Product details
- ASIN : 141659079X
- Publisher : Free Press; 1st edition (May 18, 2010)
- Language : English
- Hardcover : 272 pages
- ISBN-10 : 9781416590798
- ISBN-13 : 978-1416590798
- Item Weight : 15.2 ounces
- Dimensions : 6 x 1 x 9 inches
- Best Sellers Rank: #799,604 in Books (See Top 100 in Books)
- #1,602 in Medical Psychotherapy TA & NLP
- #1,843 in Popular Psychology Psychotherapy
- #4,825 in Medical General Psychology
- Customer Reviews:
About the author

Discover more of the author’s books, see similar authors, read author blogs and more
Customer reviews
Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.
To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.
Learn more how customers reviews work on Amazon-
Top reviews
Top reviews from the United States
There was a problem filtering reviews right now. Please try again later.
Daniel Carlat, in his book, provides an insider's look at the problems with psychiatry. Carlat was motivated to pursue a career in psychiatry because of his depressed mother's suicide. Carlat did his residency at Massachusetts General Hospital (MGH), beginning in 1992, after the introduction of second generation antidepressants like Prozac. Although his supervisors were divided between therapy and drug advocates, Carlat admits that "the main thing you learn in a psychiatric residency, then or now, is how to write prescriptions" (p. 34).
After completing his residency, Carlat, like most psychiatrists of his generation, specialized in psychopharmacology, i.e. prescribing drugs. He saw patients for 15 to 20 minute medication visits. The reason why he and other psychiatrists did this was that it was more profitable. Seeing three patients an hour for med checks allowed him to make about $180 an hour minus expenses. Seeing one patient an hour for therapy allowed him to make between $80 to $100 an hour, which is about 50% less.
Carlat talks about his experiences as a "hired gun," someone who is paid (i.e. bought out) by drug companies. Carlat worked for Wyeth Pharmaceuticals to promote the antidepressant drug Effexor to primary care doctors. He made $750 per talk. He describes that although he was officially an "expert consultant," in reality he was basically a highly-credentialed salesman. Sales reps attended his talks, and they communicated to him via body language and other feedback whether he was doing what they expected of him, i.e. to promote their product. When he tried to be more balanced and neutral, they criticized him. He eventually gave up his hired gun position.
Carlat describes his own experiences as a target of the pharmaceutical marketing machine. Ambien, a sleeping pill marketed by Sanofi-Aventis, was going off patent soon. Safoni-Aventis wanted doctors to prescribe Ambien CR ("Controlled Release"), a longer-acting drug than the original. Carlat was skeptical of the science behind the new pill. Valerie, his drug sales rep, knew that he wasn't prescribing much Ambien CR. Valerie was persistent, offering a free medical textbook as a gift. Carlat prescribed Ambien CR to a patient, subconsciously or consciously reciprocating Valerie's gift. The patient didn't like the drug due to a hangover side effect. Carlat didn't tell his patient that he prescribed Ambien CR as a favor to a drug rep.
Carlat talks about the overdiagnosis of psychiatric disorders. The DSM-IV, the "bible" of psychiatry, classifies mental disorders based on a list of symptoms. If you have five of the symptoms it mentions, you have depression. If you only have four, you don't have depression. Since this symptom-based diagnosis is ultimately based on subjective or arbitrary factors, there is no way to prevent multiplication or redefinition of disorders.
The problems with the DSM also affect clinical practice. For example, bipolar disorder is a diagnosis in the DSM based on symptoms such as alternating manic and depressive episodes. This diagnosis was intended for adults and older teenagers. Joseph Biederman and his colleagues at MGH decided to expand the diagnosis of bipolar disorder to toddlers. In 1996, Biederman published a paper reporting that nearly a quarter of children he was treating for ADHD also met his criteria for bipolar disorder. His diagnostic change led to a forty-fold increase in the number of children and adolescents treated for bipolar disorder.
What is Carlat's prescription for change in his broken profession? Carlat wants psychiatrists to go back to providing therapy, which can be balanced with medications. 15 minute medication checks are not sufficient to get to know a patient, to know what makes him tick. Sometimes changes in symptoms are not due to medications but life changes or stresses. Since most psychiatrists don't have time to inquire about anything other than symptoms and medications, they are blind to what is going on in their patients' lives. Carlat changed his own practice from exclusively 15-20 minute med checks, to somewhat longer medication sessions (20- 25 minutes), alternating with 45 minute therapy visits. He doesn't use traditional psychodynamic therapy, but instead "a version of supportive therapy that I now try to weave into the fabric of all my sessions with patients, whether they are seeing me primarily for medications or for therapy" (p. 199).
Carlat assumes that drugs are effective. In his book, he gives a number of case examples of patients whom he says were helped by medications he prescribed. But how does he know that? His conclusions about drug effectiveness are based on his own clinical observations, which derive from 15 to 25 minute appointments. How can he, or any other psychiatrist, make any conclusion about effectiveness based on such short patient visits, and in the absence of any objective lab tests?
In conclusion, this book is a well-written, honest account of systemic problems in psychiatry written by someone with an insider's perspective on the profession. Carlat does an excellent job describing the drug money corruption in psychiatry, in the overmedicalized view of a complicated phenomenon such as mental illness, and in the need for psychiatrists to better know their patients and provide some of them with therapy. He fails, however, to go far enough in questioning drug efficacy.
As one very revealing example, Carlat discusses how lax and ineffective the FDA process is for approval of psycho-active drugs. He sites (p 116-117) a study by E. Turner et al (New Eng. J. of Medicine, 2008) that analyzed all the clinical studies of 12 antidepressants approved by the FDA from 1987-2004, which included all the widely used SSRIs. Of 72 studies submitted to the FDA, 38 were positive and 36 showed negative or questionable results. And the ones that are "positive" typically show that the drug under test is only somewhat better that a placebo. The bottom-line is that while tens of millions of patients take these drugs, if one looks at all studies combined there is no real scientific evidence that these drugs are better than placebos.
Furthermore, all of the above studies are relative short duration clinical trials. In his excellent book "Anatomy of an Epidemic", Robert Whitaker points out that very few long-term studies have been carried out. Chapter 8 of Whitaker's"Anatomy" reviews the studies that have been done of long-term outcomes of patients who have taken antidepressants and basically concludes that unmedicated patients have better long-term outcomes than medicated patients, and the long-term prognosis for medicated patients is very poor. Whitaker provides convincing evidence that the rapidly growing population of chronically depressed patients is actually caused by the widespread use of anti-depressants.
While one can applaud Carlat for his strong condemnation of the pharmaceutical industry and the corruption of psychiatry, it is also somewhat shocking that Carlat himself continues to prescribe antidepressants to his patients. Throughout the book Carlat provides personal anecdotes of various patients that were "helped" by antidepressant medication. But surely he knows that the short-term benefits he describes could easily be due to the placebo effect, and he offers no knowledge ( and probably has none) of the long-term outcomes for any of these patients.
Carlat is obviously very aware of the inadequacies of the existing clinical studies, of how the "placebo effect" misleads both patients and psychiatrists into thinking that these drugs are having a positive effect, but yet he continues to prescribe them. He candidly explains how the medical insurance payment practices reward psychiatrists for 15 minute medication sessions, and how his income would be reduced by as much as 50% if he practiced traditional psychotherapy with 45-50 minute sessions.
To Carlat I say: "Physician, heal thyself".
To potential readers, I say, read "Unhinged", but also read Whitaker's "Anatomy of an Epidemic" to learn the true extent of the destruction being caused by the widespread used of psycho-active drugs.
Disclosure: I should note that I have no personal connection to the healthcare industry, have never taken psychoactive medications, nor had a mental illness. I write this review because I am shocked by the negative impact the widespread use of psychoactive prescription drugs has on our citizens, and the enormous economic cost it imposes on our society both in terms of the direct cost of the drugs, but on the ongoing costs of caring for people whose lives have been chronically impaired by their use.








